Navigation Links
Chemo-free treatment a possibility for leukemia/lymphoma
Date:3/19/2014

als like this is that you treat a patient for a period of time and often what happens is the drug doesn't work; the side effects make you stop the trial or the disease doesn't respond for very long. What is very exciting about this drug is the effects are continuing and there are no emerging side effects."

Professor Rule is now planning to run a UK study from Plymouth using the latest BTK drug in a trial against standard chemotherapy.

"The next stage will be chemo-free treatment. We've been talking about it for years and now it might be a reality," he explains. "This has the very real prospect of changing the management of these difficult forms of cancer."

Professor Simon Rule runs the only mantle cell lymphoma clinic in Europe, with one other clinic in America. As a leading clinician in mantle cell lymphoma, patients have come from around the world to seek out Professor Rule's expertise.

David Hodge's Story

David Hodge, 74, from Plymouth, was the first person in the world to be treated with this new medication and 12 months on from the start of the trial is feeling the benefits.

Prior to starting the trial in September 2012, David had only several months to live. This was due to his immune system not functioning and also following years of treatment he had become resistant to all other treatments.

Speaking on the first day of starting to take the BTK drug in September 2012, David explained what it meant to him to be taking part in the trial: "I've had three treatments, one chemo and two other treatments and although I've now had CLL (chronic lymphocytic leukemia), for 17 years, which is remarkable really, of course life is very precious and if my life can be extended I'd give God the thanks for that.

"I think with any new trial or drug, or with chemotherapy there's a little bit of trepidation but I'm a Christian and I prayed about this and I got great peace about it. I just felt, even if i
'/>"/>

Contact: Andrew Gould
andrew.gould@plymouth.ac.uk
University of Plymouth
Source:Eurekalert

Page: 1 2 3 4

Related medicine news :

1. Sepsis study comparing 3 treatment methods shows same survival rate
2. Dartmouth researchers develop new approach to chronic lymphocytic leukemia treatment
3. Gene variants protect against relapse after treatment for hepatitis C
4. PSA-testing and early treatment decreases risk of prostate cancer death
5. Emerging multi-drug resistant infections lack standard definition and treatment
6. Making treatment of rare blood disorder more affordable and effective
7. Discoveries point to more powerful cancer treatments, fewer side effects
8. A novel treatment may reduce myocardial infarction size
9. Cancer targeted treatments from space station discoveries
10. 3-D printer creates transformative device for heart treatment
11. Editorial illustrates shift away from glycemic control in diabetes treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)... May 29, 2015 Johnson & ... a confidential Risperdal lawsuit ( http://www.risperdallawsuit2014.com/ ) settlement ... due to his use of the antipsychotic medication. ... selected for the third bellwether trial to involve ... litigation underway in Pennsylvania’s Philadelphia Court of Common ...
(Date:5/29/2015)... New York (PRWEB) May 29, 2015 ... of patented products, announces that it has signed a ... a technology patent that aims to let people learn ... experts in real time. , "This is an exciting ... Room " said Scott J. Cooper, CEO and Creative ...
(Date:5/29/2015)... NY (PRWEB) May 29, 2015 The ... Today, with a circulation of approximately 250,000 and an ... nationally, through a vast social media strategy, and across ... To explore the digital version of the campaign, ... of the print publication. Inside, the actress, model and ...
(Date:5/29/2015)... York, NY (PRWEB) May 29, 2015 ... wellness, as well as a number of specific concerns ... care, stigma reduction and mental health in the workplace. ... about mental health. The campaign also brings special focus ... those individuals to speak up and seek help from ...
(Date:5/29/2015)... Ca (PRWEB) May 29, 2015 ... pain consultations with specialists, physical therapy, and injections ... experiencing mid back and/or lower back pain, Healthpointe ... epidural injections for herniated discs, disc protrusions and ... . , Healthpointe’s team of renowned surgeons ...
Breaking Medicine News(10 mins):Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 2Health News:Risperdal Lawsuit Selected as Pennsylvania’s Third Bellwether Gynecomastia Case Settles Hours Before Trial 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 2Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 3Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 4Health News:Licensing Alert! World Patent Marketing's Latest Blockbuster Licensing Deal Gets A New Twist on Technology With The Live Expert Chat Room 5Health News:Mediaplanet Brings Activism to Those Living with Mental Illness in Bew “Mental Health Awareness” Campaign 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 2Health News:Healthpointe’s Pain Management Specialists Now Providing Lumbar Epidural Injections in Los Angeles County 3
... (HealthDay News) -- Facebook is using its social-networking prowess ... The site is launching a service that will allow ... Facebook using either a special "Report Suicidal Content" link or ... who posted the worrisome comment will immediately receive an email ...
... (HealthDay News) -- Alcohol use by American teens has dropped ... and don,t believe it,s a dangerous drug, according to an ... Drug Abuse and the University of Michigan. The nationally ... 12 at 400 public and private schools found a continuing ...
... capable of halting the devastating mental decline of Alzheimer,s disease, ... PLoS one . When given to mice with ... brain damage caused by the disease. The new compound, developed ... be tested for treatment of the disease in humans in ...
... , WEDNESDAY, Dec. 14 (HealthDay News) -- Decking the ... more dangerous, a new government report finds. In ... treated in U.S. emergency departments for injuries involving holiday ... 2008 and 2009, according to the U.S. Consumer Product ...
... viruses contribute to 15-20% of human cancers worldwide. Kaposi,s ... sarcoma (KS) and two other rare lymphoproliferative malignancies. KS ... and remains a primary cause of cancer deaths in ... AIDS pandemic. Researchers at the Institute of Biotechnology and ...
... from the U.S. Agency for Healthcare Research and ... organizations anticipate, avoid and address problems that can ... The free tool, called the "Unintended Consequences ... and resources. Experts from the RAND Corporation, the ...
Cached Medicine News:Health News:Facebook Launches Service to Help Prevent Suicide 2Health News:Alcohol Use Down, Pot Use Up Among U.S. Teens 2Health News:Alzheimer's drug candidate may be first to prevent disease progression 2Health News:Alzheimer's drug candidate may be first to prevent disease progression 3Health News:Injuries Linked to Holiday Decorating on the Rise 2Health News:Injuries Linked to Holiday Decorating on the Rise 3Health News:KS-herpesvirus induces reprogramming of lymphatic endothelial cells to invasive mesenchymal cells 2Health News:Online guide helps health organizations adopt electronic health records 2
(Date:5/28/2015)... Research and Markets ( ... "United States Medical Adhesives Market Forecast and ...      (Logo: http://photos.prnewswire.com/prnh/20130307/600769) , , , The ... United States is projected to register ... device manufacturers across the US are expanding their ...
(Date:5/28/2015)... May 28, 2015 Isis Pharmaceuticals, Inc. (NASDAQ: ... Therapeutics WebcastWhen: , Thursday, June 4 at 1:00 p.m. ... , Live on the Internet.  Simply log onto our ... during the live event, a replay of the webcast ... www.isispharm.com . ABOUT ISIS PHARMACEUTICALS, INC. Isis ...
(Date:5/28/2015)... Md. , May 28, 2015 ... it will be a supporting organization of the ... and sterilization in 2016. Johnson & ... series of high-profile superbug infections in endoscopes. J&J ... health issues between 1976 and 2003 on advances ...
Breaking Medicine Technology:United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 2United States Medical Adhesives Market Forecast and Opportunities, 2020 - New Medical Innovations with 3M, Henkel Adhesive Research, Ethicon and Cyberbond Dominating 3Webcast Alert: Akcea Therapeutics Conference Call 2Webcast Alert: Akcea Therapeutics Conference Call 3PDA Announces Support for the Johnson & Johnson Kilmer Conference 2
... Science, public health, and regulatory highlights for ... nformation in this document is designed for credentialed journalists. ... April 18, 2011. (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO ... any regulatory or enforcement actions due to legal limitations. ...
... (Nasdaq: LMNX ) today announced that it expects ... Monday, May 9, 2011. A press release announcing the results ... (Logo:   http://photos.prnewswire.com/prnh/20100104/LUMINEXLOGO ) Management will ... financial results for the first quarter ended March 31, 2011, ...
Cached Medicine Technology:FDA News & Notes - Week of April 18, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 2Luminex Corporation First Quarter Earnings Release Scheduled for May 9, 2011 3
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Each handle is designed to fit a specific trephine size....
Medicine Products: